<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <meta name="author" content="第三同读" />
  <title>德鲁克日志</title>
  <style>
    html {
      color: #1a1a1a;
      background-color: #fdfdfd;
    }
    body {
      margin: 0 auto;
      max-width: 36em;
      padding-left: 50px;
      padding-right: 50px;
      padding-top: 50px;
      padding-bottom: 50px;
      hyphens: auto;
      overflow-wrap: break-word;
      text-rendering: optimizeLegibility;
      font-kerning: normal;
    }
    @media (max-width: 600px) {
      body {
        font-size: 0.9em;
        padding: 12px;
      }
      h1 {
        font-size: 1.8em;
      }
    }
    @media print {
      html {
        background-color: white;
      }
      body {
        background-color: transparent;
        color: black;
        font-size: 12pt;
      }
      p, h2, h3 {
        orphans: 3;
        widows: 3;
      }
      h2, h3, h4 {
        page-break-after: avoid;
      }
    }
    p {
      margin: 1em 0;
    }
    a {
      color: #1a1a1a;
    }
    a:visited {
      color: #1a1a1a;
    }
    img {
      max-width: 100%;
    }
    svg {
      height: auto;
      max-width: 100%;
    }
    h1, h2, h3, h4, h5, h6 {
      margin-top: 1.4em;
    }
    h5, h6 {
      font-size: 1em;
      font-style: italic;
    }
    h6 {
      font-weight: normal;
    }
    ol, ul {
      padding-left: 1.7em;
      margin-top: 1em;
    }
    li > ol, li > ul {
      margin-top: 0;
    }
    blockquote {
      margin: 1em 0 1em 1.7em;
      padding-left: 1em;
      border-left: 2px solid #e6e6e6;
      color: #606060;
    }
    code {
      font-family: Menlo, Monaco, Consolas, 'Lucida Console', monospace;
      font-size: 85%;
      margin: 0;
      hyphens: manual;
    }
    pre {
      margin: 1em 0;
      overflow: auto;
    }
    pre code {
      padding: 0;
      overflow: visible;
      overflow-wrap: normal;
    }
    .sourceCode {
     background-color: transparent;
     overflow: visible;
    }
    hr {
      background-color: #1a1a1a;
      border: none;
      height: 1px;
      margin: 1em 0;
    }
    table {
      margin: 1em 0;
      border-collapse: collapse;
      width: 100%;
      overflow-x: auto;
      display: block;
      font-variant-numeric: lining-nums tabular-nums;
    }
    table caption {
      margin-bottom: 0.75em;
    }
    tbody {
      margin-top: 0.5em;
      border-top: 1px solid #1a1a1a;
      border-bottom: 1px solid #1a1a1a;
    }
    th {
      border-top: 1px solid #1a1a1a;
      padding: 0.25em 0.5em 0.25em 0.5em;
    }
    td {
      padding: 0.125em 0.5em 0.25em 0.5em;
    }
    header {
      margin-bottom: 4em;
      text-align: center;
    }
    #TOC li {
      list-style: none;
    }
    #TOC ul {
      padding-left: 1.3em;
    }
    #TOC > ul {
      padding-left: 0;
    }
    #TOC a:not(:hover) {
      text-decoration: none;
    }
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    /* The extra [class] is a hack that increases specificity enough to
       override a similar rule in reveal.js */
    ul.task-list[class]{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      font-size: inherit;
      width: 0.8em;
      margin: 0 0.8em 0.2em -1.6em;
      vertical-align: middle;
    }
    .display.math{display: block; text-align: center; margin: 0.5rem auto;}
  </style>
</head>
<body>
<header id="title-block-header">
<h1 class="title">德鲁克日志</h1>
<p class="author">第三同读</p>
</header>
<h2 id="透过金庸读懂德鲁克">透过金庸读懂德鲁克</h2>
<p>少林为什么要有俗家弟子</p>
<p>少林寺是一个宗教机构，也是一个武学机构。少林有七十二绝技，有专门研究高级武功的达摩堂，也</p>
<p>有研究外派武功的般若堂，还有教授少林弟子的罗汉堂，还有收藏武学书籍的藏经阁。</p>
<p>少林寺这座寺庙里有大量的和尚，有大量的武功，这些大量的和尚在反复练习着大量的武功，所以，</p>
<p>少林寺里有很多高手。</p>
<p>少林寺里有两大武学研究机构，也就是达摩院和般若堂。这两个机构从少林寺一开始就有了。上千年</p>
<p>来，这两个机构也研究出了很多武功，这些武功不断强化着少林大和尚的武功。</p>
<p>然而，虽然少林寺很大。少林的和尚也很多，不过少林的武功肯定更多，毕竟研究机构是7*24小时工</p>
<p>作的，随时都有新的武功被研究出来，这些被研究出来的武功如果没有人学习，很快就会消失，变成</p>
<p>记录在藏经阁里的一本小册子。过不了多久，就消失在浩瀚的藏经阁中了。</p>
<p>怎么办?</p>
<p>这就是少林俗家弟子的作用了。</p>
<p>少林寺招收俗家弟子是没有限制的：既没有人数限制，也没有资质限制，也没有授徒限制。几乎少林</p>
<p>寺的所有人都可以收俗家弟子。当然，也要有人愿意跟你学。</p>
<p>这样一来，在少林寺的外围就有了一个庞大的群体，这个群里人数众多，资质参差不齐。这些弟子可</p>
<p>以学一些新研究出来的武功，比如判官笔，比如伏虎拳的新招式等等。</p>
<p>这样一来，除了那些真正优秀的武功在少林寺内被反复锤炼，最后形成新的绝技外，大量研究出来的</p>
<p>优秀武功也被遍布江湖的武林人士学习、传播、传承。</p>
<p>许多年后，江湖传说着：“天下武功出少林”。</p>
<p>而少林七十二绝技也想当然地“冠绝天下”。</p>
<h2 id="大纲">大纲</h2>
<h2 id="百字摘要">百字摘要</h2>
<h2 id="金庸案例">金庸案例</h2>
<h2 id="时间消耗">时间消耗</h2>
<h2 id="阅读理解">阅读理解：</h2>
<h2 id="大纲-1">大纲：</h2>
<h2 id="撰写">撰写：</h2>
<h2 id="录音">录音</h2>
<p>26 AUGUST</p>
<p>Baker Company: Research Strategy</p>
<p>Baker’s aim is to come up with a small number of drugs in each field
that are clearly superior and</p>
<p>offer significant advances to medical practice.</p>
<p>The strategy of Baker Company is completely different.</p>
<p>Its research lab, perhaps the most famous in the pharmaceutical
industry, works in an enormous</p>
<p>number of fields.</p>
<p>It does not, however, enter a field until the basic scientific
theoretical work has been done.</p>
<p>Then it goes to work.</p>
<p>Of every ten products that come out of its own laboratory, the
company itself markets no more</p>
<p>than two or three.</p>
<p>When it becomes reasonably clear that an effective drug will result
from a line of research, the</p>
<p>company carefully scrutinizes the product and, indeed, the entire
field.</p>
<p>First, is the new product likely to be medically so superior as to
become the new “standard”?</p>
<p>Second, is it likely to have major impact throughout the field of
health care and medical practice</p>
<p>rather than be confined to one specialty area, even a large one?</p>
<p>And finally, is it likely to remain the “standard” for a good many
years, rather than to be overtaken</p>
<p>by competitive products?</p>
<p>If the answer to any of these three questions is “No,” the company
will license or sell the</p>
<p>development, rather than convert it into a product of its own.</p>
<p>This has been highly profitable in two ways. It has generated
licensing income almost equal to the</p>
<p>profits the company makes on the drugs it makes and sells under its
own name.</p>
<p>And it has assured that each of the company’s products is considered
the “leader” by the medical</p>
<p>profession.</p>
<h3
id="action-point-test-your-organizations-innovative-strategy-against-that-of-baker-company.">ACTION
POINT: Test your organization’s innovative strategy against that of
Baker Company.</h3>
<p>Management Cases</p>
<h2 id="august">26 AUGUST</h2>
<h3 id="baker-company-research-strategy">Baker Company: Research
Strategy</h3>
<p>Baker’s aim is to come up with a small number of drugs in each field
that</p>
<p>are clearly superior and offer significant advances to medical
practice.</p>
<p>The strategy of Baker Company is completely different. Its research
lab,</p>
<p>perhaps the most famous in the pharmaceutical industry, works in
an</p>
<p>enormous number of fields. It does not, however, enter a field until
the basic</p>
<p>scientific theoretical work has been done. Then it goes to work. Of
every ten</p>
<p>products that come out of its own laboratory, the company itself
markets no</p>
<p>more than two or three. When it becomes reasonably clear that an
effective</p>
<p>drug will result from a line of research, the company carefully
scrutinizes the</p>
<p>product and, indeed, the entire field. First, is the new prod-uct
likely to be</p>
<p>medically so superior as to become the new “standard”? Second, is it
likely to</p>
<p>have major impact throughout the field of health care and medical
practice</p>
<p>rather than be confined to one specialty area, even a large one? And
finally, is</p>
<p>it likely to remain the “standard” for a good many</p>
<p>years, rather than to be overtaken by competitive products?</p>
<p>If the answer to any of these three questions is “No,” the company
will</p>
<p>license or sell the development, rather than convert it into a
product of its</p>
<p>own. This has been highly profitable in two ways. It has generated
licensing</p>
<p>income almost equal to the profits the company makes on the drugs it
makes</p>
<p>and sells under its own name. And it has assured that each of the
company’s</p>
<p>products is considered the “leader” by the medical profession.</p>
<h3 id="action-point">ACTION POINT:</h3>
<p>Test your organization’s innovative strategy against that of</p>
<p>Baker Company.</p>
<h4 id="management-cases">Management Cases</h4>
<script src="https://giscus.app/client.js"
        data-repo="hbaolong/hbaolong.github.io"
        data-repo-id="R_kgDOLetDQg"
        data-category="General"
        data-category-id="DIC_kwDOLetDQs4CfLEl"
        data-mapping="url"
        data-strict="0"
        data-reactions-enabled="1"
        data-emit-metadata="1"
        data-input-position="top"
        data-theme="preferred_color_scheme"
        data-lang="zh-CN"
        crossorigin="anonymous"
        async>
</script>
</body>
</html>
